These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33851345)
1. Synthesis and Biological Evaluation of [ Cao S; Tang J; Liu C; Fang Y; Ji L; Xu Y; Chen Z Mol Imaging Biol; 2021 Oct; 23(5):733-744. PubMed ID: 33851345 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [ Tang J; Liu C; Liu C; Hu Q; Fang Y; Chen Z EJNMMI Res; 2024 Aug; 14(1):78. PubMed ID: 39210186 [TBL] [Abstract][Full Text] [Related]
3. Deuterated [ Li Q; Hu Q; Tang J; Fang Y; Liu C; Liu J; Qi M; Chen Z; Zhang L Nucl Med Biol; 2023; 118-119():108334. PubMed ID: 37028197 [TBL] [Abstract][Full Text] [Related]
4. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640 [TBL] [Abstract][Full Text] [Related]
5. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT. Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810 [TBL] [Abstract][Full Text] [Related]
6. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Masilamoni G; Votaw J; Howell L; Villalba RM; Goodman M; Voll RJ; Stehouwer J; Wichmann T; Smith Y Exp Neurol; 2010 Dec; 226(2):265-73. PubMed ID: 20832405 [TBL] [Abstract][Full Text] [Related]
7. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. Zoghbi SS; Shetty HU; Ichise M; Fujita M; Imaizumi M; Liow JS; Shah J; Musachio JL; Pike VW; Innis RB J Nucl Med; 2006 Mar; 47(3):520-7. PubMed ID: 16513622 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 2beta-carbomethoxy-3beta-(4-[18F]fluorophenyl)tropane and N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane, tracers for imaging dopamine transporter in rat. Marjamäki P; Haaparanta M; Forsback S; Fagerholm V; Eskola O; Grönroos T; Koivula T; Solin O Mol Imaging Biol; 2010 Jun; 12(3):269-77. PubMed ID: 19949983 [TBL] [Abstract][Full Text] [Related]
9. Availability of dopamine transporters in heroin-dependent subjects: A Xu S; Liu Y; Li Y; Deng Y; Yuan J; Lv R; Wang Y; Zhang G; Guo Z; Fu D; Zeng H; Han M; Liu X Psychiatry Res Neuroimaging; 2017 May; 263():121-126. PubMed ID: 28376406 [TBL] [Abstract][Full Text] [Related]
10. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans. Nye JA; Votaw JR; Bremner JD; Davis MR; Voll RJ; Camp VM; Goodman MM Nucl Med Biol; 2014 Mar; 41(3):217-22. PubMed ID: 24533985 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel halo and tosyloxy nortropane derivatives as efficient precursors for the one-step synthesis of the dopamine transporter PET ligand [(18)F]FECNT. Pijarowska-Kruszyna J; Jaron AW; Kachniarz A; Kasprzak K; Kowalska A; Malkowski B; Demphel S; Dollé F; Mikolajczak R J Labelled Comp Radiopharm; 2014 Mar; 57(3):148-57. PubMed ID: 24497079 [TBL] [Abstract][Full Text] [Related]
12. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies. Voll RJ; McConathy J; Waldrep MS; Crowe RJ; Goodman MM Appl Radiat Isot; 2005 Sep; 63(3):353-61. PubMed ID: 15985372 [TBL] [Abstract][Full Text] [Related]
14. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies. Saba W; Peyronneau MA; Dollé F; Goutal S; Bottlaender M; Valette H Nucl Med Biol; 2012 Feb; 39(2):227-33. PubMed ID: 22033025 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent. Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359 [TBL] [Abstract][Full Text] [Related]
16. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain. Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT). Wuest F; Berndt M; Strobel K; van den Hoff J; Peng X; Neumeyer JL; Bergmann R Bioorg Med Chem; 2007 Jul; 15(13):4511-9. PubMed ID: 17467995 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter. Liu J; Kang J; Qi M; Tang J; Fang Y; Liu C; Hong J; Zuo J; Chen Z Bioorg Med Chem Lett; 2024 Apr; 102():129678. PubMed ID: 38408514 [TBL] [Abstract][Full Text] [Related]
19. A one-step automated synthesis of the dopamine transporter ligand [(18)F]FECNT from the chlorinated precursor. Pijarowska-Kruszyna J; Jaron A; Kachniarz A; Malkowski B; Garnuszek P; Mikolajczak R J Labelled Comp Radiopharm; 2016 Mar; 59(3):82-6. PubMed ID: 26853227 [TBL] [Abstract][Full Text] [Related]